Twin Tree Management, LP Guardant Health, Inc. Transaction History

Twin Tree Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$22.92 - $33.76 $14,141 - $20,829	617 New	617 $14,000
Q3 2022 Nov 10, 2022	BUY	$43.66 - $61.0 $292,522 - $408,700	6,700 New	6,700 $361,000
Q2 2022 Aug 11, 2022	SELL	$28.82 - $77.35 $720,730 - $1.93 Million	-25,008 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$48.25 - $100.49 $1.21 Million - $2.51 Million	25,008 New	25,008 $1.66 Million
Q4 2021 Feb 10, 2022	SELL	$88.71 - $120.43 $51,096 - $69,367	-576 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $56,891 - $76,129	576 New	576 $72,000
Q4 2020 Feb 12, 2021	SELL	$99.96 - $135.93 $16,293 - $22,156	-163 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$80.32 - $111.8 $411,479 - $572,751	-5,123 Reduced 96.92%	163 $18,000
Q2 2020 Aug 12, 2020	SELL	$60.49 - $97.5 $601,028 - $968,760	-9,936 Reduced 65.27%	5,286 $429,000
Q1 2020 May 13, 2020	BUY	$59.04 - $88.81 $898,706 - $1.35 Million	15,222 New	15,222 $1.06 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.51B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.